These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37630190)

  • 41. Elevated Plasma Aβ42 in Cognitively Impaired Individuals Taking ACE Inhibitor Antihypertensives.
    Regenold WT; Blumenthal JB; Loreck DJ; Mordecai KL; Scarinzi G; Doddi SR; Adler L
    Am J Alzheimers Dis Other Demen; 2017 Sep; 32(6):347-352. PubMed ID: 28449585
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Perindopril, a centrally active angiotensin-converting enzyme inhibitor, prevents cognitive impairment in mouse models of Alzheimer's disease.
    Dong YF; Kataoka K; Tokutomi Y; Nako H; Nakamura T; Toyama K; Sueta D; Koibuchi N; Yamamoto E; Ogawa H; Kim-Mitsuyama S
    FASEB J; 2011 Sep; 25(9):2911-20. PubMed ID: 21593435
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Design, synthesis and evaluation of novel 2-butyl-4-chloroimidazole derived peptidomimetics as Angiotensin Converting Enzyme (ACE) inhibitors.
    Jallapally A; Addla D; Bagul P; Sridhar B; Banerjee SK; Kantevari S
    Bioorg Med Chem; 2015 Jul; 23(13):3526-33. PubMed ID: 25922179
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis.
    Li NC; Lee A; Whitmer RA; Kivipelto M; Lawler E; Kazis LE; Wolozin B
    BMJ; 2010 Jan; 340():b5465. PubMed ID: 20068258
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dysregulation of ACE-1 in Normal Aging and the Early Stages of Alzheimer's Disease.
    MacLachlan R; Kehoe PG; Miners JS
    J Gerontol A Biol Sci Med Sci; 2022 Sep; 77(9):1775-1783. PubMed ID: 35396835
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Safety profile of benazepril in essential hypertension.
    MacNab M; Mallows S
    Clin Cardiol; 1991 Aug; 14(8 Suppl 4):IV33-7; discussion IV51-5. PubMed ID: 1893640
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ameliorative effect of nicergoline on cognitive function through the PI3K/AKT signaling pathway in mouse models of Alzheimer's disease.
    Zang G; Fang L; Chen L; Wang C
    Mol Med Rep; 2018 May; 17(5):7293-7300. PubMed ID: 29568940
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Angiotensin converting enzyme serum activities: Relationship with Alzheimer's disease.
    Zhuang S; Wang X; Wang HF; Li J; Wang HY; Zhang HZ; Xing CM
    Brain Res; 2016 Nov; 1650():196-202. PubMed ID: 27608957
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dementia of Alzheimer's disease and other neurodegenerative disorders--memantine, a new hope.
    Sonkusare SK; Kaul CL; Ramarao P
    Pharmacol Res; 2005 Jan; 51(1):1-17. PubMed ID: 15519530
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Does use of antihypertensive drugs affect the incidence or progression of dementia? A systematic review.
    Shah K; Qureshi SU; Johnson M; Parikh N; Schulz PE; Kunik ME
    Am J Geriatr Pharmacother; 2009 Oct; 7(5):250-61. PubMed ID: 19948301
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Angiotensin converting enzyme and endothelial nitric oxide synthase DNA polymorphisms and late onset Alzheimer's disease.
    Alvarez R; Alvarez V; Lahoz CH; Martínez C; Peña J; Sánchez JM; Guisasola LM; Salas-Puig J; Morís G; Vidal JA; Ribacoba R; Menes BB; Uría D; Coto E
    J Neurol Neurosurg Psychiatry; 1999 Dec; 67(6):733-6. PubMed ID: 10567488
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Therapeutic resistance to angiotensin converting enzyme (ACE) inhibition is related to pharmacodynamic and -kinetic factors in 5/6 nephrectomized rats.
    Windt WA; van Dokkum RP; Kluppel CA; Jeronimus-Stratingh CM; Hut F; de Zeeuw D; Henning RH
    Eur J Pharmacol; 2008 Feb; 580(1-2):231-40. PubMed ID: 18036585
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Safety profiles of the angiotensin-converting enzyme inhibitors.
    Warner NJ; Rush JE
    Drugs; 1988; 35 Suppl 5():89-97. PubMed ID: 3063490
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ACE overexpression in myelomonocytic cells: effect on a mouse model of Alzheimer's disease.
    Koronyo-Hamaoui M; Shah K; Koronyo Y; Bernstein E; Giani JF; Janjulia T; Black KL; Shi PD; Gonzalez-Villalobos RA; Fuchs S; Shen XZ; Bernstein KE
    Curr Hypertens Rep; 2014 Jul; 16(7):444. PubMed ID: 24792094
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Early intervention with a small molecule inhibitor for tumor necrosis factor-α prevents cognitive deficits in a triple transgenic mouse model of Alzheimer's disease.
    Gabbita SP; Srivastava MK; Eslami P; Johnson MF; Kobritz NK; Tweedie D; Greig NH; Zemlan FP; Sharma SP; Harris-White ME
    J Neuroinflammation; 2012 May; 9():99. PubMed ID: 22632257
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2.
    Ferrario CM; Jessup J; Chappell MC; Averill DB; Brosnihan KB; Tallant EA; Diz DI; Gallagher PE
    Circulation; 2005 May; 111(20):2605-10. PubMed ID: 15897343
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Current status of renin-aldosterone angiotensin system-targeting anti-hypertensive drugs as therapeutic options for Alzheimer's disease.
    Ashby EL; Kehoe PG
    Expert Opin Investig Drugs; 2013 Oct; 22(10):1229-42. PubMed ID: 23800077
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The angiotensin AT4 receptor subtype as a target for the treatment of memory dysfunction associated with Alzheimer's disease.
    Wright JW; Harding JW
    J Renin Angiotensin Aldosterone Syst; 2008 Dec; 9(4):226-37. PubMed ID: 19126664
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Is inhibition of the renin-angiotensin system a new treatment option for Alzheimer's disease?
    Kehoe PG; Wilcock GK
    Lancet Neurol; 2007 Apr; 6(4):373-8. PubMed ID: 17362841
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of a centrally active angiotensin converting enzyme inhibitor, perindopril, on cognitive performance in chronic cerebral hypo-perfusion rats.
    Yamada K; Horita T; Takayama M; Takahashi S; Takaba K; Nagata Y; Suzuki N; Kanda T
    Brain Res; 2011 Nov; 1421():110-20. PubMed ID: 21981801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.